Relmada Therapeutics, Inc.
RLMD
$6.27
$0.559.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 764.58% | 107.10% | -74.34% | -70.73% | -67.64% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 131.42% | 10.29% | -38.94% | -11.70% | -20.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 750.92% | 105.22% | -73.33% | -70.28% | -67.22% |
|
|
|||||
| Total Current Assets | 750.92% | 105.22% | -73.33% | -70.28% | -67.22% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.36% | -11.36% | 0.00% | -58.96% | -48.96% |
| Total Assets | 750.32% | 105.17% | -73.30% | -70.27% | -67.21% |
|
|
|||||
| Total Accounts Payable | 353.08% | -62.02% | -38.05% | -67.38% | -75.62% |
| Total Accrued Expenses | 80.52% | -21.09% | -34.92% | -29.65% | -44.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 146.43% | -37.52% | -35.83% | -46.16% | -57.68% |
|
|
|||||
| Total Current Liabilities | 146.43% | -37.52% | -35.83% | -46.16% | -57.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 49,748.00% | 23,475.56% | 1,654.76% | -- | -- |
| Total Liabilities | 217.44% | -27.24% | -33.20% | -45.82% | -57.62% |
|
|
|||||
| Common Stock & APIC | 37.48% | 16.02% | 2.69% | 3.36% | 3.99% |
| Retained Earnings | -8.94% | -8.95% | -9.03% | -11.29% | -12.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 874.72% | 143.54% | -80.13% | -74.06% | -68.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 874.72% | 143.54% | -80.13% | -74.06% | -68.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 874.72% | 143.54% | -80.13% | -74.06% | -68.85% |
|
|
|||||